These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35117677)

  • 1. CRISPR-Cas genome editing tool: a narrow lane of cancer therapeutics with potential blockades.
    Bhatkar D; Sarode SC; Sarode GS; Patil S; Sharma NK
    Transl Cancer Res; 2020 Apr; 9(4):3135-3141. PubMed ID: 35117677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research.
    Yang Y; Xu J; Ge S; Lai L
    Front Med (Lausanne); 2021; 8():649896. PubMed ID: 33748164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing: A New Horizon for Oral and Craniofacial Research.
    Yu N; Yang J; Mishina Y; Giannobile WV
    J Dent Res; 2019 Jan; 98(1):36-45. PubMed ID: 30354846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions.
    Fu L; Li Z; Ren Y; Yu H; Liu B; Qiu Y
    Biochem Pharmacol; 2023 Mar; 209():115449. PubMed ID: 36754153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruptive non-disruptive applications of CRISPR/Cas9.
    Schmid-Burgk JL
    Curr Opin Biotechnol; 2017 Dec; 48():203-209. PubMed ID: 28633080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruptive Technology: CRISPR/Cas-Based Tools and Approaches.
    Patsali P; Kleanthous M; Lederer CW
    Mol Diagn Ther; 2019 Apr; 23(2):187-200. PubMed ID: 30945167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing.
    Asmamaw M; Zawdie B
    Biologics; 2021; 15():353-361. PubMed ID: 34456559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/dCas-mediated transcriptional and epigenetic regulation in plants.
    Pan C; Sretenovic S; Qi Y
    Curr Opin Plant Biol; 2021 Apr; 60():101980. PubMed ID: 33401227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
    Bayarsaikhan D; Bayarsaikhan G; Lee B
    Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.